Do Predictors of Mortality in Upper Gastrointestinal Bleeding Include A Weekend Time of Admission?

There have been marked evolutions in the management of patients with nonvariceal upper gastrointestinal bleeding (NVUGIB), and more specifically peptic ulcer bleeding, over the past 5 to 7 years that include the introduction of efficacious therapies such as endoscopic hemostasis with a single modality (preferably not just the sole injection of epinephrine), or a combination of methods, followed by high-dose intravenous proton pump inhibition.¹ Regardless, early risk stratification remains a cornerstone of appropriate management and the explicit use of validated scoring schemes is encouraged.